Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001172661-25-001284·ARMISTICE CAPITAL, LLC
Schedule 13G ownership disclosure
INTENSITY THERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 45828J103
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Armistice Capital, LLC
Shares: 1,126,868.00 · Class: 8.13%
- Steven Boyd
Shares: 1,126,868.00 · Class: 8.13%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001284
- Form type
- SCHEDULE 13G
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership